A Shot At Bio ChIndia: India’s Biological E Tests Waters In China

After bagging deals with GSK and Novartis, Indian vaccine maker Biological E is confidently setting sights on its next big target: China. Despite challenges aplenty, the company is banking on strong R&D and manufacturing to ease entry – but first it needs to find the right distributor.